Phospholipase A2, Hydroxyl Radicals, and Lipid Peroxidation in Transient Cerebral Ischemia-Reference-Cited by-同舟云学术

Phospholipase A2, Hydroxyl Radicals, and Lipid Peroxidation in Transient Cerebral Ischemia

Published:2003-10 Issue:5 Volume:5 Page:647-654
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Adibhatla Rao Muralikrishna¹,Hatcher James F.,Dempsey Robert J.

Affiliation:

1. Department of Neurological Surgery, Cardiovascular Research Center, University of Wisconsin, Madison, WI 53792

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/152308603770310329

Reference63 articles.

1. Citicoline mechanisms and clinical efficacy in cerebral ischemia

2. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia

3. Effects of Citicoline on Phospholipid and Glutathione Levels in Transient Cerebral Ischemia

4. Citicoline: neuroprotective mechanisms in cerebral ischemia

5. Polyamines and central nervous system injury: spermine and spermidine decrease following transient focal cerebral ischemia in spontaneously hypertensive rats

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of cardiolipin in regulating and treating atherosclerotic cardiovascular diseases;European Journal of Pharmacology;2024-09

2. Citicoline modulates inflammatory signaling pathways in the spleen of rats exposed to gamma-radiation;Immunopharmacology and Immunotoxicology;2024-07-03

3. Effects of Low-Dose Citicoline on the Electrical Conduction Function of the Crushed Sciatic Nerve of Rats;Dubai Medical Journal;2023-07-05

4. Phospholipase and radiation-mediated membrane dynamics;Phospholipases in Physiology and Pathology;2023

5. PLA2: Implications in neurological disorders as a prospective therapeutic target;Phospholipases in Physiology and Pathology;2023